A cell therapy approach based on iPSC-derived midbrain organoids for the restoration of motor function in a Parkinson’s disease mouse model
Parkinson's disease (PD) is a neurodegenerative disease characterized by the degeneration of dopaminergic (DA) neurons in the substantia nigra and loss of DA transmission in the striatum, thus making cell transplantation an effective treatment strategy. Here, we develop a cellular therapy based...
Main Authors: | Chong-Lei Fu, Bo-Cheng Dong, Xi Jiang, Dan Li, Jun Yao |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-01-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844024002652 |
Similar Items
-
The multifaceted role of LRRK2 in Parkinson's disease: From human iPSC to organoids
by: Asmaa Oun, et al.
Published: (2022-10-01) -
Midbrain Organoids: A New Tool to Investigate Parkinson’s Disease
by: Lisa Maria Smits, et al.
Published: (2020-05-01) -
Patient-Derived Midbrain Organoids to Explore the Molecular Basis of Parkinson's Disease
by: Benjamin Galet, et al.
Published: (2020-09-01) -
Cryopreservation Maintains Functionality of Human iPSC Dopamine Neurons and Rescues Parkinsonian Phenotypes In Vivo
by: Dustin R. Wakeman, et al.
Published: (2017-07-01) -
Mitochondrial Phenotypes in Parkinson’s Diseases—A Focus on Human iPSC-Derived Dopaminergic Neurons
by: Leonie M. Heger, et al.
Published: (2021-12-01)